Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg

DRUG2 trials

Sponsors

Pharmacotherapies for Alcohol and Substance Use Disorders Alliance

Conditions

Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)

Phase 1

Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study

CompletedNCT04827056

Pharmacotherapies for Alcohol and Substance Use Disorders AllianceAlcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)

Start: 2021-11-09End: 2023-06-02Updated: 2023-10-26

Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study

RecruitingNCT06335407

Pharmacotherapies for Alcohol and Substance Use Disorders AllianceAlcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD)

Start: 2025-07-28End: 2026-05-31Target: 10Updated: 2025-10-27